Champions Oncology Upgraded to Buy by Craig-Hallum
Craig-Hallum Initiates Champions Oncology(CSBR.US) With Buy Rating, Announces Target Price $6
Champions Oncology Analyst Ratings
Craig-Hallum Maintains Champions Oncology(CSBR.US) With Buy Rating
Craig-Hallum Maintains Champions Oncology(CSBR.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Accolade (ACCD) and Champions Oncology (CSBR)
Champions Oncology Analyst Ratings
Analysts' Top Healthcare Picks: Acurx Pharmaceuticals (ACXP), Champions Oncology (CSBR)
Craig Hallum Trims Champions Oncology Price Target to $9 From $10, Maintains Buy Rating
Analysts Offer Insights on Healthcare Companies: Champions Oncology (CSBR), Walgreens Boots Alliance (WBA) and Harrow Health (HROW)
Champions Oncology Analyst Ratings
Benchmark Co. Keeps Their Hold Rating on Champions Oncology (CSBR)
Craig-Hallum Remains a Buy on Champions Oncology (CSBR)
Craig Hallum Adjusts Champions Oncology Price Target to $10 From $12, Maintains Buy Rating